[DOI] [PubMed] [Google Scholar] 23.Pham H., Marathe C.S., Phillips L.K., Trahair L.G., Hatzinikolas S., Huynh L., Wu T., Nauck M.A., Rayner C.K., Horowitz M., et al
I love that I have a coach who supports and uplifts me, said Kelsey
Adding gastric inhibitory polypeptide (GIP) receptor agonists amplifies the gastric effects of GLP-1s, as the higher weight loss promised by the dual action tirzepatide, compared with semaglutide, exemplifies 2
Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line
In contrast to ghrelin, gastric endocrine cells also release an anorexigenic peptide, nesfatin 214,225
Countries in North America, particularly the US, have the highest rates of diabetes and obesity in the world